147 related articles for article (PubMed ID: 33718239)
1. Sex-Based Heterogeneity in the Clinicopathological Characteristics and Prognosis of Breast Cancer: A Population-Based Analysis.
Han Y; Wang J; Wang Z; Xu B
Front Oncol; 2021; 11():642450. PubMed ID: 33718239
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis.
Han Y; Wang J; Wang Z; Xu B
Cancer Control; 2021; 28():10732748211044355. PubMed ID: 34654324
[TBL] [Abstract][Full Text] [Related]
3. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract][Full Text] [Related]
4. Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.
Wang Y; Chen K; Yang Y; Tan L; Chen L; Zhu L; Su F; Liu X; Li S
Ann Transl Med; 2019 Oct; 7(20):536. PubMed ID: 31807518
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer.
Li H; Zhang Y; Teh MS; Limaye S; Cavalcante FP; Shen JB
Transl Cancer Res; 2023 Sep; 12(9):2371-2378. PubMed ID: 37859736
[TBL] [Abstract][Full Text] [Related]
6. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
7. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
8. Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
Zhao J; Wang B; Zhao J; Mao Y; Liu J; Yang Y
Thorac Cancer; 2020 Nov; 11(11):3107-3116. PubMed ID: 32930510
[TBL] [Abstract][Full Text] [Related]
9. Men and women show similar survival outcome in stage IV breast cancer.
Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
[TBL] [Abstract][Full Text] [Related]
10. Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database.
Xie J; Ying YY; Xu B; Li Y; Zhang X; Li C
Ther Adv Med Oncol; 2019; 11():1758835919889003. PubMed ID: 31798694
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis.
Han Y; Wang J; Xu B
Breast; 2020 Dec; 54():114-120. PubMed ID: 32979771
[TBL] [Abstract][Full Text] [Related]
12. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
13. Survival Comparisons Between Early Male and Female Breast Cancer Patients.
Wang K; Wang QJ; Xiong YF; Shi Y; Yang WJ; Zhang X; Li HY
Sci Rep; 2018 Jun; 8(1):8900. PubMed ID: 29891971
[TBL] [Abstract][Full Text] [Related]
14. Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis.
Lian W; Zheng J; Chen D
Transl Cancer Res; 2020 Oct; 9(10):5969-5978. PubMed ID: 35117209
[TBL] [Abstract][Full Text] [Related]
15. Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis.
Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Younus J; Perera F; Tai P
Cureus; 2015 Oct; 7(10):e355. PubMed ID: 26623210
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Analysis of Primary Breast Signet Ring Cell Carcinoma and Mucinous Breast Adenocarcinoma: A SEER Population-Based Study.
Wang S; Zhang Y; Yin F; Zhang X; Yang Z; Wang X
Front Oncol; 2021; 11():783631. PubMed ID: 34956901
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognostic factors of male breast cancer
Sang G; Pan H; Lu C; Sun R; Zha X; Wang S; Zhu D
Transl Cancer Res; 2021 May; 10(5):2199-2209. PubMed ID: 35116538
[TBL] [Abstract][Full Text] [Related]
18. The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study.
Han Y; Wu Y; Xu H; Wang J; Xu B
Int J Clin Oncol; 2022 Apr; 27(4):707-716. PubMed ID: 35041101
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.
Shimomura A; Nagahashi M; Kumamaru H; Aogi K; Asaga S; Hayashi N; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Niikura N; Ogo E; Tamura K; Tanakura K; Yoshida M; Yamamoto Y; Imoto S; Jinno H
Breast Cancer; 2022 Nov; 29(6):985-992. PubMed ID: 35733033
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics and survival of male breast cancer.
Liu D; Xie G; Chen M
Int J Clin Oncol; 2014 Apr; 19(2):280-7. PubMed ID: 23640121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
